Literature DB >> 2579641

Complexes of rat alpha 1-macroglobulin and subtilisin are endocytosed by parenchymal liver cells.

J Bergsma, M K Boelen, A M Duursma, W G Schutter, J M Bouma, M Gruber.   

Abstract

Rat alpha 1-macroglobulin was isolated from plasma. Gel electrophoresis of the denatured and reduced protein showed two bands, with Mr values of 163 000 and 37 000. The large subunit contained an autolytic site. This subunit was also split after reaction of the macroglobulin with trypsin. Electron microscopy showed that the macroglobulin changed towards a more compact conformation after reaction with this proteinase. Subtilisin, or alpha 1-macroglobulin, was labelled with a sucrose-containing radio-iodinated group that stays in lysosomes after endocytosis and breakdown of the tagged protein. After intravenous injection into rats, alpha 1-macroglobulin was cleared from plasma with first-order kinetics, showing a half-life of about 9 h, whereas complexes of alpha 1-macroglobulin and subtilisin were cleared with half-lives of only 3 min. Liver contained about 60% of the label at 30 min after injection of complexes. About 90% of the liver radioactivity was found in parenchymal cells isolated after perfusion of the liver with a collagenase solution. Subcellular fractionation indicated a lysosomal localization of the complexes. We conclude that endocytosis by parenchymal liver cells is the major cause of the rapid clearance of alpha 1-macroglobulin-proteinase complexes from plasma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579641      PMCID: PMC1144679          DOI: 10.1042/bj2260075

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue.

Authors:  C DE DUVE; B C PRESSMAN; R GIANETTO; R WATTIAUX; F APPELMANS
Journal:  Biochem J       Date:  1955-08       Impact factor: 3.857

2.  Isolation and partial characterization of two related trypsin binding alpha-macroglobulins of dog plasma.

Authors:  K Ohlsson
Journal:  Biochim Biophys Acta       Date:  1971-04-27

3.  Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Escherichia coli.

Authors:  R C Valentine; B M Shapiro; E R Stadtman
Journal:  Biochemistry       Date:  1968-06       Impact factor: 3.162

4.  2 -acute phase globulin in rat serum. Purification, determination and interaction with trypsin.

Authors:  K Ganrot
Journal:  Biochim Biophys Acta       Date:  1973-01-25

5.  Serum protease inhibitors in the blood clearance of subtilisin A.

Authors:  M T Debanne; E Regoeczi; J Dolovich
Journal:  Br J Exp Pathol       Date:  1973-10

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Elimination of 125-I-trypsin alpha-macroglobulin complexes from blood by reticuloendothelial cells in dogs.

Authors:  K Ohlsson
Journal:  Acta Physiol Scand       Date:  1971-02

8.  Determination of alpha-2-macroglobulin as trypsin-protein esterase.

Authors:  P O Ganrot
Journal:  Clin Chim Acta       Date:  1966-10       Impact factor: 3.786

9.  [Biochemical study of alpha 1-macroglobulin in rabbit serum. II. Metabolism].

Authors:  H Mouray; R Got; J Moretti
Journal:  Biochim Biophys Acta       Date:  1965-09-13

10.  Ultrastructural studies of human and rabbit alpha-M-globulins.

Authors:  B Bloth; B Chesebro; S E Svehag
Journal:  J Exp Med       Date:  1968-04-01       Impact factor: 14.307

View more
  2 in total

1.  Proteases and protease inhibitors in taurocholate-induced acute pancreatitis in rats.

Authors:  P Kruse; E Hage; A Lasson
Journal:  Int J Pancreatol       Date:  1999-04

2.  Biosynthesis and regulation of rat alpha 1-inhibitor3, a negative acute-phase reactant of the macroglobulin family.

Authors:  T Geiger; Y Lamri; T A Tran-Thi; F Gauthier; G Feldmann; K Decker; P C Heinrich
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.